✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Natco Pharma Ltd.

NATCOPHARM

Market Cap
₹15,472 Cr.
P/E
10.91

Natco Pharma Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
15,472 Cr
PE
PE
10.91
Prom Holding
Prom Holding
49.42 %
ROE (%)
ROE (%)
24.79
ROCE (%)
ROCE (%)
30.32
Div Yield (%)
Div Yield (%)
0.58
Sales
Sales
4,078 Cr
OPM (%)
OPM (%)
35.22 %
Debt to Equity
Debt to Equity
0.04
Institutions
Institutions
22.82 %
Individual < 2 lac
Individual < 2 lac
20.13 %
No. of Shareholders
No. of Shareholders
4.11 L
View more
Edit Ratio's

About

Natco Pharma Limited is a vertically integrated pharmaceutical company with a focus on researc… Read more
Low
789
52W Range
High
1227
  • Natco Pharma
  • Jubilant Pharmova
  • Alembic Pharma
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

11 Yes

Positive for this company

3 Neutral

Neutral for this company

3 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

0.07 %
(as of Jul 22)
Historic
Anti - Diabetes - Market Share
0.74 %
(as of Jul 22)
Historic
Anti-Infectives - Market Share
16.71 %
(as of Nov 21)
Historic
Antineo Plastic - Market Share
0.11 %
(as of Nov 21)
Historic
Blood Related - Market Share
0.56 %
(as of Jul 22)
Historic
Cardiovascular - Market Share
30 %
(as of Mar 19)
Source/Historic
Copaxone - Market Share

Revenue mix

Product Wise Break-Up

Segment Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up - Formulation

Location Wise Break-Up

Therapeutic Area Break-Up - Formulation

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Domestic Sales Growth - YoY (%)
      Source
    • US DMF Filings (.)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Brands

    Afinitor
    Aubagio
    Imbruvica
    Kyprolis
    Nexavar
    Pomalyst
    Revlimid
    Sovaldi
    Tarceva
    Tykerb
    Zytiga

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • Laurus Labs Ltd.
    • Shaily Engineering Plastics Ltd.
    • Take Solutions Ltd.

    FAQs on Natco Pharma Ltd. Business

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release May Aug Sep Dec Mar Jun Sep Dec Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Sep
    Investor Presentation Feb May May Jul Aug Nov Feb Mar Jun Sep Dec Mar Jun Sep Dec Feb Mar Jun Aug Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Dec Mar Jun Sep Dec Mar Sep Dec Mar Jun Sep Dec Sep Dec Mar Sep
    Conference Call Feb Jun Mar Jun Nov Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Natco Pharma Ltd.
    A Deep Dive Into Natco Pharma - Numbers and Narratives
    Natco Pharma: Imminent Growth Cycle (?) - ValuePickr
    NatcoPharma - Complex generics focused manufacturer - Value Educator
    Business Analysis Of Natco Pharma - Value Educator
    Interview with Mr Rajeev Nannapaneni, Vice Chairman & CEO at Natco Pharma - Moneylife
    Natco Pharma: Chasing Optionalities - Ankush Agrawal
    Natco Pharma: Business Model Simplified - JST Investments
    Chasing Optionalities - SOIC
    View the discussion on ValuePickr
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material